Purchases and Sales Made in Q2 2023 in Cogent Biosciences, Inc. (COGT)
This table provides information about the institutional ownership of Cogent Biosciences, Inc. (COGT) during Q2 2023. The information is specifically focused on institutions that hold shares of Cogent Biosciences, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2023
Q2 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-75.5K- 30.48% |
$744K - $1M
|
172K
$1.59M
|
|
|
Jul 18, 2023
Q2 2023
|
Allspring Global Investments Holdings, LLC
|
SELL
|
- |
-92.2K- 99.53% |
$909K - $1.22M
|
434
$4.01K
|
|
|
Aug 11, 2023
Q2 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-95.2K- 82.18% |
$937K - $1.26M
|
20.6K
$191K
|
|
|
Aug 14, 2023
Q2 2023
|
Algert Global LLC
San Francisco, CA |
SELL
|
- |
-98.2K- 48.63% |
$968K - $1.3M
|
104K
$960K
|
|
|
Aug 10, 2023
Q2 2023
|
Citigroup Inc
|
SELL
|
- |
-115K- 59.03% |
$1.13M - $1.52M
|
79.7K
$737K
|
|
|
Jul 10, 2023
Q2 2023
|
Sg Americas Securities, LLC
|
SELL
|
- |
-122K- 75.83% |
$1.2M - $1.61M
|
38.9K
$360K
|
|
|
Aug 08, 2023
Q2 2023
|
Candriam S.C.A.
|
SELL
|
- |
-165K- 17.57% |
$1.62M - $2.18M
|
772K
$7.15M
|
|
|
May 14, 2024
Q2 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-189K- 34.11% |
$1.86M - $2.5M
|
365K
$3.37M
|
|
|
Aug 14, 2023
Q2 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-189K- 34.11% |
$1.86M - $2.5M
|
365K
$3.37M
|
|
|
Aug 14, 2023
Q2 2023
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
- |
-189K- 24.07% |
$1.87M - $2.51M
|
597K
$5.52M
|
|
|
Aug 14, 2023
Q2 2023
|
Logos Global Management LP
San Francisco, CA |
SELL
|
- |
-200K- 20.0% |
$1.97M - $2.65M
|
800K
$7.4M
|
|
|
Aug 11, 2023
Q2 2023
|
Vr Adviser, LLC
New York, NY |
SELL
|
- |
-201K- 4.11% |
$1.98M - $2.66M
|
4.68M
$43.3M
|
|
|
Aug 14, 2023
Q2 2023
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-228K- 60.91% |
$2.24M - $3.02M
|
146K
$1.35M
|
|
|
Aug 14, 2023
Q2 2023
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-251K- 18.07% |
$2.47M - $3.32M
|
1.14M
$10.5M
|
|
|
Aug 14, 2023
Q2 2023
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-260K- 56.23% |
$2.56M - $3.44M
|
202K
$1.87M
|
|
|
Aug 14, 2023
Q2 2023
|
State Street Corp
Boston, MA |
SELL
|
- |
-300K- 8.74% |
$2.95M - $3.97M
|
3.13M
$28.9M
|
|
|
Aug 14, 2023
Q2 2023
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-344K- 20.7% |
$3.39M - $4.56M
|
1.32M
$12.2M
|
|
|
Aug 14, 2023
Q2 2023
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
SELL
|
- |
-658K- 30.46% |
$6.48M - $8.71M
|
1.5M
$13.9M
|
|
|
Aug 14, 2023
Q2 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-1.16M- 89.6% |
$11.4M - $15.4M
|
135K
$1.25M
|